MCL1 modulator (X-Rx/Merachem)

N/A

Report date: 2025/06/11 10:34:34
NME

Base Information

Drug NameMCL1 modulator (X-Rx/Merachem)
Drug Alias NameMCL1 modulator (X-Rx)myeloid cell leukemia1 modulator (X-Rx)
ClassificationSmall molecules
Mechanisms of ActionApoptosis inhibitorsInduced myeloid leukemia cell differentiation protein Mcl-1 modulators
TargetsInduced myeloid leukemia cell differentiation protein Mcl-1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesX-Rx Discovery Inc
China Registration ClassN/A

Develop Information

Active CompaniesMercachem Holding BVX-Rx Discovery Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A